Literature DB >> 21477941

Interfractional dose variations in intensity-modulated radiotherapy with breath-hold for pancreatic cancer.

Mitsuhiro Nakamura1, Keiko Shibuya, Akira Nakamura, Takehiro Shiinoki, Yukinori Matsuo, Manabu Nakata, Akira Sawada, Takashi Mizowaki, Masahiro Hiraoka.   

Abstract

PURPOSE: To investigate the interfractional dose variations for intensity-modulated radiotherapy (RT) combined with breath-hold (BH) at end-exhalation (EE) for pancreatic cancer. METHODS AND MATERIALS: A total of 10 consecutive patients with pancreatic cancer were enrolled. Each patient was fixed in the supine position on an individualized vacuum pillow with both arms raised. Computed tomography (CT) scans were performed before RT, and three additional scans were performed during the course of chemoradiotherapy using a conventional RT technique. The CT data were acquired under EE-BH conditions (BH-CT) using a visual feedback technique. The intensity-modulated RT plan, which used five 15-MV coplanar ports, was designed on the initial BH-CT set with a prescription dose of 39 Gy at 2.6 Gy/fraction. After rigid image registration between the initial and subsequent BH-CT scans, the dose distributions were recalculated on the subsequent BH-CT images under the same conditions as in planning. Changes in the dose-volume metrics of the gross tumor volume (GTV), clinical target volume (CTV = GTV + 5 mm), stomach, and duodenum were evaluated.
RESULTS: For the GTV and clinical target volume (CTV), the 95th percentile of the interfractional variations in the maximal dose, mean dose, dose covering 95% volume of the region of structure, and percentage of the volume covered by the 90% isodose line were within ±3%. Although the volume covered by the 39 Gy isodose line for the stomach and duodenum did not exceed 0.1 mL at planning, the volume covered by the 39 Gy isodose line for these structures was up to 11.4 cm(3) and 1.8 cm(3), respectively.
CONCLUSIONS: Despite variations in the gastrointestinal state and abdominal wall position at EE, the GTV and CTV were mostly ensured at the planned dose, with the exception of 1 patient. Compared with the duodenum, large variations in the stomach volume receiving high-dose radiation were observed, which might be beyond the negligible range in achieving dose escalation with intensity-modulated RT combined with BH at EE. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21477941     DOI: 10.1016/j.ijrobp.2011.01.050

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  8 in total

1.  Optimization of treatment planning workflow and tumor coverage during daily adaptive magnetic resonance image guided radiation therapy (MR-IGRT) of pancreatic cancer.

Authors:  Sven Olberg; Olga Green; Bin Cai; Deshan Yang; Vivian Rodriguez; Hao Zhang; Jin Sung Kim; Parag J Parikh; Sasa Mutic; Justin C Park
Journal:  Radiat Oncol       Date:  2018-03-24       Impact factor: 3.481

2.  Clinical results of dynamic tumor tracking intensity-modulated radiotherapy with real-time monitoring for pancreatic cancers using a gimbal mounted linac.

Authors:  Yoko Goto; Ryo Ashida; Akira Nakamura; Satoshi Itasaka; Keiko Shibuya; Mami Akimoto; Nobutaka Mukumoto; Shigemi Matsumoto; Masashi Kanai; Hiroyoshi Isoda; Toshihiko Masui; Yuzo Kodama; Mitsuhiro Nakamura; Kyoichi Takaori; Takashi Mizowaki; Masahiro Hiraoka
Journal:  Oncotarget       Date:  2018-05-04

3.  Development of a four-axis moving phantom for patient-specific QA of surrogate signal-based tracking IMRT.

Authors:  Nobutaka Mukumoto; Mitsuhiro Nakamura; Masahiro Yamada; Kunio Takahashi; Mami Akimoto; Yuki Miyabe; Kenji Yokota; Shuji Kaneko; Akira Nakamura; Satoshi Itasaka; Yukinori Matsuo; Takashi Mizowaki; Masaki Kokubo; Masahiro Hiraoka
Journal:  Med Phys       Date:  2016-12       Impact factor: 4.071

4.  Interfraction positional variation in pancreatic tumors using daily breath-hold cone-beam computed tomography with visual feedback.

Authors:  Mitsuhiro Nakamura; Mami Akimoto; Tomohiro Ono; Akira Nakamura; Shinsuke Yano; Manabu Nakata; Satoshi Itasaka; Takashi Mizowaki; Keiko Shibuya; Masahiro Hiraoka
Journal:  J Appl Clin Med Phys       Date:  2015-03-08       Impact factor: 2.102

5.  Impact of interfractional anatomical variation and setup correction methods on interfractional dose variation in IMPT and VMAT plans for pancreatic cancer patients: A planning study.

Authors:  Ryo Ashida; Mitsuhiro Nakamura; Michio Yoshimura; Takashi Mizowaki
Journal:  J Appl Clin Med Phys       Date:  2020-04-30       Impact factor: 2.102

6.  Variation in accumulated dose of volumetric-modulated arc therapy for pancreatic cancer due to different beam starting phases.

Authors:  Makoto Sasaki; Mitsuhiro Nakamura; Nobutaka Mukumoto; Yoko Goto; Yoshitomo Ishihara; Manabu Nakata; Naozo Sugimoto; Takashi Mizowaki
Journal:  J Appl Clin Med Phys       Date:  2019-09-20       Impact factor: 2.102

7.  Effects of interportal error on dose distribution in patients undergoing breath-holding intensity-modulated radiotherapy for pancreatic cancer: evaluation of a new treatment planning method.

Authors:  Toru Takakura; Mitsuhiro Nakamura; Keiko Shibuya; Manabu Nakata; Akira Nakamura; Yukinori Matsuo; Takehiro Shiinoki; Kyoji Higashimura; Teruki Teshima; Masahiro Hiraoka
Journal:  J Appl Clin Med Phys       Date:  2013-09-06       Impact factor: 2.102

8.  Dosimetric effects of anatomical changes during fractionated photon radiation therapy in pancreatic cancer patients.

Authors:  Astrid van der Horst; Antonetta C Houweling; Geertjan van Tienhoven; Jorrit Visser; Arjan Bel
Journal:  J Appl Clin Med Phys       Date:  2017-10-04       Impact factor: 2.102

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.